No licensing fee is payable for an initial application or renewal application
for a wholesale licence for a hazardous poison (each a
"later application" ) if—
(a) an initial application or renewal application for a manufacturing licence or wholesale licence for an S4 medicine, or a manufacturing licence for an S8 medicine, (each a
"first application" ) has been made, and not withdrawn or refused, under the Medicines and Poisons (Medicines) Regulation 2021 ; and
(b) the site the subject of the later application is the same as the site the subject of the first application; and
(c) the term proposed for the later application ends no later than the last month of—(i) the term proposed for the first application; or(ii) if the chief executive has granted the first application—the term of the substance authority granted on the first application; and
(d) all fees payable under the Act for the first application have been paid.